Mechanism of UTP-Modulated Attenuation at the Pyre Gene Of

Total Page:16

File Type:pdf, Size:1020Kb

Mechanism of UTP-Modulated Attenuation at the Pyre Gene Of Tlhe EMBO Journal vol.3 no.12 pp.2857-2861, 1984 Mechanism of UTP-modulated attenuation at the pyrE gene of Escherichia coli: an example of operon polarity control through the coupling of translation to transcription Fons Bonekamp, Kire Clemmesen1, Olle Karlstrom and (rpoBC) suggesting that the pyr genes are regulated by the Kaj Frank Jensen level of saturation of RNA polymerase with UTP (Jensen et University of Copenhagen, Institute of Biological Chemistry B, S0lvgade al., 1982). 83, DK-1307 Copenhagen K, and 'University of Copenhagen, Institute of We have previously shown that pyrE is the second gene of Microbiology, 0. Farimagsgade 2A, DK-1353 Copenhagen K, Denmark an operon preceded by an open reading frame (orJE) 238 Communicated by A.Munch-Petersen codons long, which directs the formation of considerable quantities of a polypeptide (mol. wt. 25 497) of unknown The pyrE gene of Escherichia coli is part of an operon where function (Poulsen et 1983, Transcription of it is preceded by an unknown gene (orfE) that ends 8 bp al., 1984). the operon is initiated at two in front of a before the start of the symmetry of promoters orfE at fre- the UTP-modulated pyrE quency independent of the cellular concentration attenuator. On a plasmid we have inserted this of UTP. attenuator However, a fraction of the mRNA region in a synthetic cloning site early in lacZ. The resulting only chains reach thepyrE gene due to a UTP a structure contains the lac promoter-operator, the first few regulated attenuation at transcription terminator in the intercistronic space between orfE and pyrE codons of lacZ, 42 bp of DNA from the orfE end, the pyrE et and an (Poulsen al., 1984) (Figure 1). attenuator, in-frame fusion pyrE-IacZ+. The syn- The present experiments aim at elucidating the mechanism thetic cloning sites have been used to vary the length and behind this attenuation, in particular the role translation reading frame of the translation that begins at the lacZ start of of orfE in the control. In essence we have taken thepyrE and proceeds towards the attenuator. of attenu- The effects these ator out of its normal remove variations on pyrE attenuation were determined by monitor- context to it from other poss- ible regulations, e.g., on ing the synthesis of from the level of transcription initiation. ,B-galactosidase the pyrE-lacZ Thus we hybrid gene in grown have inserted fragment A (Figure 1) containing the cells with either low or high pools of end of orfE, the attenuator region, and the beginning ofpyrE UTP. Thus, a very low level of pyrE expression was observ- into the very first part of the lacZ gene on a plasmid. Since ed, regardless of UTP pool size, when the translation from the resulting pyrE-lacZ fusion is in-frame, the lacZ start ended 31 or 62 nucleotide residues upstream to ,B-galactosidase the pyrE activity could be measured to monitor pyrE expression. The attenuator symmetry, but a proper UTP controlled lacZ translation start and attenuation could be established if this translation ended only the cloning region following it were 8 essential for testing the effect of translation into the attenu- bp before the symmetry region of the attenuator (as the ator region. minor native orfE gene) or 10 bp after this structure. However, a By manipulations of the DNA in the clon- ing region we single 'leader read from could modify the length of a short artificial peptide' only frequently used codons peptide read from the lacZ translation start gave a high level of pyrE expression both at high and low towards the attenuator. The effects on UTP pools. These observations indicate that the coupling the UTP modulation of attenu- ation could then be measured. we between transcription and translation determines the degree From the results conclude of mRNA chain terminations at the pyrE attenuator. The level of saturation of the transcribing RNA polymerase with A UTP determines the tightness of this coupling, but the codon usage in the translated area also seems crucial. Key words: attenuation modulated by UTPAeader peptide variations/polarity control/pyrimidine nucleotide biosynthe- sis/translational coupling to transcription Introduction ThepyrE gene of Escherichia coli encodes the enzyme orotate phosphoribosyltransferase that catalyses one of the reactions in the de novo synthesis of UMP - the precursor of all other pyrimidine nucleotides. The gene is located at 81 min on the "PUF" OPRTase E. coli chromosome and is transcribed in a counter-clockwise (Mr:25,497) (Mr: 23,326) direction towards dut (Bachman and Brooks Low, 1980; Fig. 1. Structure and expression of the orfE-pyrE operon. Symbols and Poulsen et al., 1983). Expression ofpyrE as well as ofpyrB is abbreviations: P2, P1, the two promoters of the operon; atn, attenuator. controlled by the UTP pool, being low when the concen- orfE: 238 triplet codons long open reading frame. T(5), T 8) blocks of five tration of UTP is high and vice versa (Schwartz and Neuhard, and eight thymidylate residues flanking the symmetry of t(he attenuator. 1975; Kelln et al., 1975; Pierard et al., 1976; Turnbough, The arrows and wavy lines underneath indicate the transcripts and gene 1983). So far, the identified mutants products of the operon, respectively. 'PUF': protein of unknown function. only regulatory that OPRTase: orotate phosphoribosyltransferase. A: 510-bp TaqI-TaqI show elevated expression ofpyrE and pyrB in the presence of fragment used for the construction of IacPO-pyrE4acZI gene fusion a high UTP pool are defective in their RNA polymerase herein (see text). ©C IRL Press Limited, Oxford, England. 2857 F.Bonekamp et al. pUC 9 HaeH+ XmaI P E HPABXB Av T atn T P-PROXIMAL P-DISTAL S1 PPP2 l-7-M I WIJ FUSION FUSION Ligation, L-]J ilil J pKCL4 orf E - - pyrE I Ligation pMLB1034 XmaI (pKCL 11) p HpA TaqI HT p ABamHI PKCL 10 l[Fj~4.~psniai~PJrP8NACC,L L HPi/P1L~latnT_ 101. Hindf J E /Ap I ISi P E HPAB Av p pQ i NpTatn T Li!-- J pKCL5 PKCL 13 (pKCL 10) NcoIPNNS1~~~~Ll9@t,OnS....l JL1 S1 _PKCL104- AAGCTT HindX p1 Ligation + Klenow pot. p F p F p1T atn AAGCTAGCTT igation pKCL 15 - L~~~~=~~~4~IcTL1CLO0 Av P E PAB Av P P p pT atn T, Rt LiP- IL- J pKCL6 pKCL 6 L_ _J.w- i b L PJ I L1t-,-PK~CL 106 am am am: P Pp P pT atn T Fig. 2. Construction of cloning vehicles. A lacZ-translational fusion vehicle Pi I PKCL 107 pKCL4 was constructed by cloning the 254-bp HaeII-XmaI fragment of pCN 102 pCN1O21 --- 7 * .... .6mzj..i.PIf -1i_ ==X pUCG8 I pUC9 into pMLB1034 opened with XmaI. pKCL4 contains the EcoRl site I of pMLB1034 and the lac promoter and operator with a cloning region CLONING REGION I \ within the start of the lacZ gene. This cloning region is in-frame with the I,TI rest of lacZ allowing formation of active fl-galactosidase. A derivative of this plasmid (pKCL5), in which the lacZ gene is brought out-of-frame, was constructed by deleting the small BamHl fragment of the cloning region. Since the further cloning strategy required as few Accl sites as possible (see Figure 3), the 3320-bp EcoRI-AvaI fragments of pKCL4 and 5, where the two AvaI sites in lacZ were left uncut, were in turn ligated to the ,3- lactamase encoding AvaI-EcoRI fragment of pBR327. The resulting plasmids are called pKCLI I and 10, respectively. The fact that the two ends of lacZ in pKCL5 are out-of-frame by - 1 bp inside the cloning region could be used to construct an amber codon in the start of this region by opening the HindIII site, filling it up with Klenow polymerase, and religating. While the cloning region was thus brought back in-frame Fig. 3. Construction of lacPO-pyrE-lacZ+ gene fusions. The 510-bp Taql- with the rest of lacZ, an amber codon was generated within the former TaqI fragment of pPP2 (fragment A, Figure 1) was cloned behind amino HindIII site. The proper clones were selected by testing for f-galactosidase acid codon no. 8 of the lacZ gene in partially Accl digested plasmid activity after cross-streaking with 080pSU3 +, which carries an amber pKCL1O (Figure 2), where the AccI site in lacZ was left uncut. This suppressor and which made those colonies that contained the amber codon resulted in a 1acPO-pyrE-lacZ+ fusion with ,B-galactosidase activity turn blue on XG plates after infection. The sites for the restriction (plasmid pKCLI01). This plasmid also contains a coding frame for a endonucleases are indicated as follows: A, site for the endonuclease AccI; 'leader peptide' originating at the lacZ start (see Figure 4). To be able to Av, AvaI; B, BamHI; E, EcoRl; H, HindIII; P, PstI; X, XmaI. P (in change the nature (length and reading frame) of the leader-translation, we bold type) indicates the position of the lac promoter; the arrow indicates deleted the smaller PstI-PstI fragment, which contains the lacZ start and the direction of transcription from this promoter; am, amber codon. the linker, from pKCLIOI. The larger PstI-PstI fragment, containing the pyrE attenuator and the hybrid pyrE-lacZ+ gene was used for the cloning that the attenuation frequency is controlled through UTP- of similar small PstI-Pstl fragments, manipulated in the restriction sites of the linker region. This was done in the following way. Plasmid pKCLIO induced variations in the coupling between translation and was cut with HindIlI, treated with SI nuclease, and religated.
Recommended publications
  • Mirnas and Lncrnas As Novel Therapeutic Targets to Improve Cancer Immunotherapy
    cancers Review miRNAs and lncRNAs as Novel Therapeutic Targets to Improve Cancer Immunotherapy Maria Teresa Di Martino 1,*,† , Caterina Riillo 1,† , Francesca Scionti 2, Katia Grillone 1 , Nicoletta Polerà 1, Daniele Caracciolo 1, Mariamena Arbitrio 3, Pierosandro Tagliaferri 1 and Pierfrancesco Tassone 1 1 Department of Clinical and Experimental Medicine, Magna Graecia University of Catanzaro, 88100 Catanzaro, Italy; [email protected] (C.R.); [email protected] (K.G.); [email protected] (N.P.); [email protected] (D.C.); [email protected] (P.T.); [email protected] (P.T.) 2 Institute of Research and Biomedical Innovation (IRIB), Italian National Council (CNR), 98164 Messina, Italy; [email protected] 3 Institute of Research and Biomedical Innovation (IRIB), Italian National Council (CNR), 88100 Catanzaro, Italy; [email protected] * Correspondence: [email protected] † These authors contributed equally. Simple Summary: Cancer onset and progression are promoted by high deregulation of the immune system. Recently, major advances in molecular and clinical cancer immunology have been achieved, offering new agents for the treatment of common tumors, often with astonishing benefits in terms of prolonged survival and even cure. Unfortunately, most tumors are still resistant to current immune therapy approaches, and basic knowledge of the resistance mechanisms is eagerly awaited. We Citation: Di Martino, M.T.; Riillo, C.; focused our attention on noncoding RNAs, a class of RNA that regulates many biological processes Scionti, F.; Grillone, K.; Polerà, N.; by targeting selectively crucial molecular pathways and that, recently, had their role in cancer cell Caracciolo, D.; Arbitrio, M.; immune escape and modulation of the tumor microenvironment identified, suggesting their function Tagliaferri, P.; Tassone, P.
    [Show full text]
  • Transcription Initiation Sites of the Leucine Operons of Salmonella Typhimurium and Escherichia Coli
    J. Mol. Biol. (1983) 170, 39-59 Transcription Initiation Sites of the Leucine Operons of Salmonella typhimurium and Escherichia coli ROBERT M. GEMMILL~', JUDITH W. JONES, GEORGE W. HAUGHN AND JOSEPH M. CALVO Section of Biochemistry, Molecular and Cell Biology Cornell University, Ithaca, IV. Y. 14853, U.S.A. (Received 13 September 1982, and in revised form 15 June 1983) Evidence for a transcription attenuation site downstream from the leu promoter was obtained by transcription experiments in vitro. Most transcription initiated in vitro from teuP is terminated prematurely, resulting in the synthesis of a 160 nucleotide leader RNA. We define here the point at which transcription is initiated in vitro and in vivo and demonstrate that the site of premature termination is between the promoter and the first structural gene (leuA). Additional nucleotide sequences are presented that extend the known sequence 200 base-pairs upstream and 300 base-pairs downstream from leuP. The location of the promoter-proximal end of cistron leuA was deduced by comparing nucleotide sequence data with the sequence of the ten amino acids at the N-terminus of a-isopropylmalate synthase. To facilitate the isolation of quantities of material for sequencing experiments, the enzyme was isolated from a plasmid-containing strain, CV605, grown under conditions of leucine limitation. Under such conditions, about 20% of the total soluble protein of strain CV605 is a-isopropylmalate synthase and another 20~/o is fl-isopropylmalate dehydrogenase (leuB product). 1. Introduction Leucine biosynthesis in enteric bacteria is catalyzed by three enzymes whose levels are co-ordinately regulated by the intracellular concentration of leucine (Calvo et al., 1969a).
    [Show full text]
  • Noncoding RNA E
    Noncoding RNA E. Desgranges, S. Marzi, K. Moreau, P. Romby, Isabelle Caldelari To cite this version: E. Desgranges, S. Marzi, K. Moreau, P. Romby, Isabelle Caldelari. Noncoding RNA. Microbiology Spectrum, American Society for Microbiology, 2019, 7 (2), 10.1128/microbiolspec.GPP3-0038-2018. hal-02112074 HAL Id: hal-02112074 https://hal.archives-ouvertes.fr/hal-02112074 Submitted on 27 Oct 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Gram-positive pathogens, 3rd Edition (ASM) Staphylococcus section Chapter 5: non-coding RNA Desgranges, E. 1, Marzi, S. 1, Moreau, K. 2, Romby, P1, and Caldelari I1*. 1Université de Strasbourg, CNRS, Architecture et Réactivité de l’ARN, UPR9002, F-67000 Strasbourg, France 2CIRI, International Center for Infectiology Research, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, École Normale Supérieure de Lyon, Hospices Civils de Lyon, Univ Lyon, F-69008, Lyon, France *corresponding author General introduction Regulatory RNAs have been identified in many bacteria, and in pathogenic bacteria such as Staphylococcus aureus, where they play major roles in the regulation of virulence or metabolic proteins synthesis, beside transcriptional factors and two component systems (Bischoff and Romby, 2016, Tomasini et al., 2014, Guillet et al., 2013, Caldelari et al., 2011).
    [Show full text]
  • The Arginine Attenuator Peptide Interferes with the Ribosome Peptidyl Transferase Center
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Texas A&M University The Arginine Attenuator Peptide Interferes with the Ribosome Peptidyl Transferase Center Jiajie Wei, Cheng Wu, and Matthew S. Sachs Department of Biology, Texas A&M University, College Station, Texas, USA The fungal arginine attenuator peptide (AAP) is encoded by a regulatory upstream open reading frame (uORF). The AAP acts as a nascent peptide within the ribosome tunnel to stall translation in response to arginine (Arg). The effect of AAP and Arg on ri- bosome peptidyl transferase center (PTC) function was analyzed in Neurospora crassa and wheat germ translation extracts using Downloaded from the transfer of nascent AAP to puromycin as an assay. In the presence of a high concentration of Arg, the wild-type AAP inhib- ited PTC function, but a mutated AAP that lacked stalling activity did not. While AAP of wild-type length was most efficient at stalling ribosomes, based on primer extension inhibition (toeprint) assays and reporter synthesis assays, a window of inhibitory function spanning four residues was observed at the AAP’s C terminus. The data indicate that inhibition of PTC function by the AAP in response to Arg is the basis for the AAP’s function of stalling ribosomes at the uORF termination codon. Arg could inter- fere with PTC function by inhibiting peptidyltransferase activity and/or by restricting PTC A-site accessibility. The mode of PTC inhibition appears unusual because neither specific amino acids nor a specific nascent peptide chain length was required for AAP to inhibit PTC function.
    [Show full text]
  • Construction of L-Threonine Overproducing Strains Of
    Agric. Biol Chem., 47 (10), 2329-2334, 1983 2329 Construction of L-Threonine Overproducing Strains of Escherichia coli K-12 Using Recombinant DNATechniques Kiyoshi Miwa, Takayasu Tsuchida, Osamu Kurahashi, Shigeru Nakamori, Konosuke Sano and HaruoMomose Central Research Laboratories ofAjinomoto Co., Inc., Kawasaki-ku, Kawasaki 210, Japan Received April 4, 1983 The threonine operon of Escherichia coli was cloned in plasmid pBR322, using a threonine producing mutant, /?IM4, as the DNAdonor. A recombinant plasmid, pAJ294, that contains the whole threonine operon was obtained. No. 29-4, a transformant of /?IM4 with pAJ294, had about eleven copies of pAJ294, five times higher homoserine dehydrogenase activity (coded by the thrA gene), and about three times higher threonine productivity than those of /?IM4. No. 29-4 produced 13.4g/liter of l-threonine from 30 g/liter of glucose in the culture medium. Threonine biosynthesis is known to be reg- mutant /?IM44) was used as the DNA donor and the ulated by two mechanisms in E. coli. One is recipient. Threonine auxotrophic mutants, No. 1 thrA, feedback inhibition by L-threonine of a bi- No. 43 thrB, No. 313 thrC, No. 44 thr (not identified) and functional enzyme, aspartokinase I (AK-I)- No. 255 thr (not identified), were derived from /?IM4 and used as the recipients. Plasmid pBR3225) was used as the homoserine dehydrogenase I (HDH-I), and vector. another is multivalent repression of the thre- onine biosynthetic enzymes by L-threonine Media. L medium6) and Davis'7) minimal medium were used. Amino acids (100 /ig/ml), thiamine-HCl (1 /ig/ml), plus L-isoleucine1} through the attenuation ampicillin (lOOjUg/ml) and tetracycline (20/ig/ml) were mechanism.2'3) Wehave previously construct- added when required.
    [Show full text]
  • Attenuation Regulation of Amino Acid Biosynthetic Operons in Proteobacteria: Comparative Genomics Analysis
    FEMS Microbiology Letters 234 (2004) 357–370 www.fems-microbiology.org Attenuation regulation of amino acid biosynthetic operons in proteobacteria: comparative genomics analysis Alexey G. Vitreschak a,*, Elena V. Lyubetskaya a, Maxim A. Shirshin a, Mikhail S. Gelfand a,b, Vassily A. Lyubetsky a,c a Institute for Information Transmission Problems, Russian Academy of Sciences, Bolshoi Karetnyi per. 19, Moscow 127994, GSP-4, Russia b State Scientific Centre GosNIIGenetica, 1-st Dorozhny pr. 1, Moscow 113545, Russia c Institute for strategic stability, Atomic Energy of the Russian Federation, Luganskaya street, 9, 115304 Moscow, Russia Received 26 December 2003; received in revised form 16 March 2004; accepted 2 April 2004 First published online 16 April 2004 Abstract Candidate attenuators were identified that regulate operons responsible for biosynthesis of branched amino acids, histidine, threonine, tryptophan, and phenylalanine in c- and a-proteobacteria, and in some cases in low-GC Gram-positive bacteria, Thermotogales and Bacteroidetes/Chlorobi. This allowed us not only to describe the evolutionary dynamics of regulation by at- tenuation of transcription, but also to annotate a number of hypothetical genes. In particular, orthologs of ygeA of Escherichia coli were assigned the branched chain amino acid racemase function. Three new families of histidine transporters were predicted, or- thologs of yuiF and yvsH of Bacillus subtilis, and lysQ of Lactococcus lactis. In Pasteurellales, the single bifunctional aspartate kinase/homoserine dehydrogenase gene thrA was predicted to be regulated not only by threonine and isoleucine, as in E. coli, but also by methionine. In a-proteobacteria, the single acetolactate synthase operon ilvIH was predicted to be regulated by branched amino acids-dependent attenuators.
    [Show full text]
  • The Trp Operon (BIOT 4006: Genetics and Molecular Biology)
    The trp Operon (BIOT 4006: Genetics and Molecular Biology) Dr. Saurabh Singh Rathore Department of Biotechnology MGCU Introduction • Synthesis of the enzymes involved in the biosynthesis of tryptophan is controlled by the trptophan/trp operon in E. coli. • Charles Yanofsky and others have studied in detail the working of the five structural genes and the close regulatory elements of the trp operon. • The precursor for biosynthesis of the amino acid tryptophan is “chorismic acid”. • The five structural genes of the trp operon code for enzymes required for conversion of chorismic acid to tryptophan. • There are two levels of regulation of this operon: 1. Repression: works at the level of transcription initiation 2. Attenuation: works at the level of transcription termination Repression of the trp operon • The repression regulation works negatively. • The trpR gene coding for repressor of trp operon is distantly located from the operon itself. • P1 is for primary promoter region and it contains the operator (O) region. • P2 is a weak promoter found at that end of the trpD gene which is more far from the operator. Its function is to increase the basal transcription level of the trpC, trpB & trpA genes. • There are two termination regions, namely t and t’ placed downstream to the trpA gene. The trpL denotes a region for a mRNA leader sequence (162 nucleotides in length). E. Coli trp operon organization • The biosynthesis of tryptophan is shown at the bottom. • The five structural genes coding for enzymes needed for tryptophan biosynthesis are: trpE, trpD, trpC, trpB & trpA. • trpL is the regulatory segment. • The gene lengths and the intergenic distances are shown as bp’s.
    [Show full text]
  • S41467-020-20181-5.Pdf
    ARTICLE https://doi.org/10.1038/s41467-020-20181-5 OPEN The iron-dependent repressor YtgR is a tryptophan-dependent attenuator of the trpRBA operon in Chlamydia trachomatis ✉ Nick D. Pokorzynski 1,2, Nathan D. Hatch2, Scot P. Ouellette 2 & Rey A. Carabeo 2 The trp operon of Chlamydia trachomatis is organized differently from other model bacteria. It contains trpR, an intergenic region (IGR), and the biosynthetic trpB and trpA open-reading 1234567890():,; frames. TrpR is a tryptophan-dependent repressor that regulates the major promoter (PtrpR), while the IGR harbors an alternative promoter (PtrpBA) and an operator sequence for the iron- dependent repressor YtgR to regulate trpBA expression. Here, we report that YtgR repression at PtrpBA is also dependent on tryptophan by regulating YtgR levels through a rare triple- tryptophan motif (WWW) in the YtgCR precursor. Inhibiting translation during tryptophan limitation at the WWW motif subsequently promotes Rho-independent transcription ter- mination of ytgR, thereby de-repressing PtrpBA. Thus, YtgR represents an alternative strategy to attenuate trpBA expression, expanding the repertoire for trp operon attenuation beyond TrpL- and TRAP-mediated mechanisms described in other bacteria. Furthermore, repurposing the iron-dependent repressor YtgR underscores the fundamental importance of maintaining tryptophan-dependent attenuation of the trpRBA operon. 1 School of Molecular Biosciences, College of Veterinary Medicine, Washington State University, Pullman, WA, USA. 2 Department of Pathology and ✉ Microbiology, University of Nebraska Medical Center, Omaha, NE, USA. email: [email protected] NATURE COMMUNICATIONS | (2020) 11:6430 | https://doi.org/10.1038/s41467-020-20181-5 | www.nature.com/naturecommunications 1 ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-20181-5 ccess to the amino acid tryptophan is an important TrpL-mediated tryptophan-dependent cis-attenuation27.
    [Show full text]
  • Design Rules of Synthetic Non-Coding Rnas in Bacteria Young Je Lee And
    1 Design rules of synthetic non-coding RNAs in bacteria 2 Young Je Lee and Tae Seok Moon* 3 4 Department of Energy, Environmental and Chemical Engineering, Washington University in St. 5 Louis, St. Louis, MO, 63130, USA 6 7 * To whom correspondence should be addressed. 8 Tae Seok Moon 9 One Brookings Dr., Box 1180 10 St. Louis, MO 63130, USA 11 Tel: +1 (314) 935-5026 12 Fax: +1 (314) 935-7211 13 Email: [email protected] 14 15 16 17 18 19 20 21 22 23 1 24 Abstract 25 One of the long-term goals of synthetic biology is to develop designable genetic parts with 26 predictable behaviors that can be utilized to implement diverse cellular functions. The discovery 27 of non-coding RNAs and their importance in cellular processing have rapidly attracted researchers’ 28 attention towards designing functional non-coding RNA molecules. These synthetic non-coding 29 RNAs have simple design principles governed by Watson-Crick base pairing, but exhibit 30 increasingly complex functions. Importantly, due to their specific and modular behaviors, 31 synthetic non-coding RNAs have been widely adopted to modulate transcription and translation of 32 target genes. In this review, we summarize various design rules and strategies employed to 33 engineer synthetic non-coding RNAs. Specifically, we discuss how RNA molecules can be 34 transformed into powerful regulators and utilized to control target gene expression. With the 35 establishment of generalizable non-coding RNA design rules, the research community will shift 36 its focus to RNA regulators from protein regulators. 37 38 Keywords 39 Non-coding RNA, antisense RNA, STAR, toehold switch, CRISPR, aptazyme 40 41 42 43 44 45 46 2 47 Contents 48 1.
    [Show full text]
  • Versatile RNA-Sensing Transcriptional Regulators for Engineering Genetic Networks
    Versatile RNA-sensing transcriptional regulators for engineering genetic networks Julius B. Lucksa,b,1,2, Lei Qia,1, Vivek K. Mutalikc, Denise Wanga, and Adam P. Arkina,c,d,3 aDepartment of Bioengineering, University of California, Berkeley, CA 94720; bMiller Institute for Basic Research in Science, Berkeley, CA 94720; cPhysical Biosciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720; and dCalifornia Institute for Quantitative Sciences (QB3), Berkeley, CA 94720 Edited* by Jennifer A. Doudna, University of California, Berkeley, CA, and approved April 11, 2011 (received for review October 19, 2010) The widespread natural ability of RNA to sense small molecules and There is a potential to greatly simplify genetic networks by regulate genes has become an important tool for synthetic biology directly propagating signals as RNA molecules (Fig. 1B). One in applications as diverse as environmental sensing and metabolic way to do this would be to implement network connections with engineering. Previous work in RNA synthetic biology has engi- RNA regulatory elements that sense an input RNA signal and neered RNA mechanisms that independently regulate multiple regulate the synthesis of an output RNA signal. Antisense-RNA- targets and integrate regulatory signals. However, intracellular mediated transcription attenuators are ideal candidate mechan- regulatory networks built with these systems have required pro- isms to use as a starting point for engineering this capability. teins to propagate regulatory signals. In this work, we remove this Much like riboswitches (15), they reside in 5′ untranslated regions requirement and expand the RNA synthetic biology toolkit by en- of mRNA and regulate the synthesis of downstream protein-cod- gineering three unique features of the plasmid pT181 antisense- ing regions by terminating transcription through RNA structural RNA-mediated transcription attenuation mechanism.
    [Show full text]
  • One-Step of Tryptophan Attenuator Inactivation and Promoter Swapping
    Gu et al. Microbial Cell Factories 2012, 11:30 http://www.microbialcellfactories.com/content/11/1/30 RESEARCH Open Access One-step of tryptophan attenuator inactivation and promoter swapping to improve the production of L-tryptophan in Escherichia coli Pengfei Gu, Fan Yang, Junhua Kang, Qian Wang and Qingsheng Qi* Abstract Background: L-tryptophan is an aromatic amino acid widely used in the food, chemical and pharmaceutical industries. In Escherichia coli, L-tryptophan is synthesized from phosphoenolpyruvate and erythrose 4-phosphate by enzymes in the shikimate pathway and L-tryptophan branch pathway, while L-serine and phosphoribosylpyrophosphate are also involved in L-tryptophan synthesis. In order to construct a microbial strain for efficient L-tryptophan production from glucose, we developed a one step tryptophan attenuator inactivation and promoter swapping strategy for metabolic flux optimization after a base strain was obtained by overexpressing the tktA, mutated trpE and aroG genes and inactivating a series of competitive steps. Results: The engineered E. coli GPT1002 with tryptophan attenuator inactivation and tryptophan operon promoter substitution exhibited 1.67 ~ 9.29 times higher transcription of tryptophan operon genes than the control GPT1001. In addition, this strain accumulated 1.70 g l-1 L-tryptophan after 36 h batch cultivation in 300-mL shake flask. Bioreactor fermentation experiments showed that GPT1002 could produce 10.15 g l-1 L-tryptophan in 48 h. Conclusions: The one step inactivating and promoter swapping is an efficient method for metabolic engineering. This method can also be applied in other bacteria. Background arabino-heptulosonate-7-phosphate (DAHP), and then L-tryptophan is an essential aromatic amino acid for proceeds to chorismate, a key intermediate product humans and animals which can be used as food additive, leading to the formation of L-tryptophan, L-tyrosine, infusion liquids, pellagra treatment, sleep induction and and L-phenylalanine (Figure 1).
    [Show full text]
  • Mg2+-Dependent Translational Speed Bump Acts to Regulate
    COMMENTARY + Mg2 -dependent translational speed bump acts to regulate gene transcription COMMENTARY Kelly T. Hughesa,1 DNA Transcription in Bacteria (7). Normally, an mRNA in bacteria is described as The central dogma of molecular biology states that having a 5′UTR between the transcriptional start-site DNA is transcribed (by RNA polymerase) to messenger and the translation initiation codon. The 5′UTR is often RNA that is then translated (by ribosomes) into protein used in translational control by controlling the mRNA (1). The regulation of gene expression can occur at any secondary structure to either expose or occlude the ri- level: transcription, mRNA stability, translation that in- bosome binding site upstream of the translation initia- cludes mRNA folding to reveal or occlude translation tion codon. Terminator sequences upstream of the initiation sites, and protein modification and stability. In structural genes of many bacterial operon systems are eukaryotes, the processes of transcription and trans- used to effect transcriptional control, such as in the lation are carried out in the cell nucleus and cytoplasm, case of riboswitches. Riboswitches allow metabolites to respectively. In bacteria, which lack a nucleus, the pro- control alternative mRNA secondary structures in the cesses of transcription and translation are coupled. This 5′UTR region to facilitate either the formation or de- provides an evolutionary target that is unique to bacteria stabilization of a transcriptional terminator (8, 9). for controlling gene expression. Many gene regulatory mechanisms in bacteria use transcription–translation Control of DNA Transcription by Charged tRNA coupling to affect whether transcription elongation The discovery of a role for charged tRNA species in through specific single or multigene operons continues transcriptional control of the histidine biosynthetic or terminates in response to changing concentrations of operons led to the discovery that translation played the metabolic product associated with a given operon.
    [Show full text]